Cubist Systematic Strategies, LLC Infla Rx N.V. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.75 $4,881 - $10,738	3,905 Added 139.46%	6,705 $10,000
Q3 2023 Nov 14, 2023	BUY	$2.66 - $4.33 $7,448 - $12,124	2,800 New	2,800 $8,000
Q2 2020 Aug 14, 2020	SELL	$4.59 - $8.96 $206 - $403	-45 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.65 - $6.08 $119 - $273	45 New	45 $0
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $27,888 - $470,373	-9,114 Closed	0 $0

Q1 2019 May 15, 2019	BUY	$31.16 - $48.62 $283,992 - $443,122	9,114 New	9,114 $344,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.